You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CVKD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CVKD's short-term liabilities ($672.36k) exceed its short-term assets ($541.36k)
Short-term Liabilities Financials
CVKD's long-term liabilities ($1.05M) exceed its short-term assets ($541.36k)
NASDAQ: CVKD) Cadrenal Therapeutics trades on the NASDAQ under the ticker symbol CVKD. Cadrenal Therapeutics stock quotes can also be displayed as NASDAQ: CVKD.
What is the 52 week high and low for Cadrenal Therapeutics (NASDAQ: CVKD)?
(NASDAQ: CVKD) Cadrenal Therapeutics's 52-week high was $6.75, and its 52-week low was $2.60. It is currently -61.19% from its 52-week high and 0.77% from its 52-week low.
How much is Cadrenal Therapeutics's stock price per share?
(NASDAQ: CVKD) Cadrenal Therapeutics stock price per share is $2.62 today (as of Jan 27, 2023).
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.